CIK 0001662774 · Non-accelerated filer<br>Smaller reporting company
IRulya Therapeutics Inc.
Sign in to watch- Ticker
- IRLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 901024039
- Phone
- 203-208-8994
- Business address
- 101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
- Former names
- Quince Therapeutics, Inc., Cortexyme, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 70 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | McLoughlin Margaret Director | Grant or award · Director Stock Option (Right to Buy) | +19,547 | 19,547 | ||
| 2026-01-02 | Lamond David Director | Grant or award · Director Stock Option (Right to Buy) | +29,423 | 29,423 | ||
| 2026-01-02 | Bray June Director | Grant or award · Director Stock Option (Right to Buy) | +18,724 | 18,724 | ||
| 2025-12-26 | Benatti Luca Director | Sale | −50,000 | $3.47 | $174K | 39,179 |
| 2025-12-10 | Thye Dirk CEO and CMO | Gift | −739,885 | 255,000 | ||
| 2025-12-10 | Thye Dirk CEO and CMO | Gift | +739,885 | 739,885 | ||
| 2025-12-05 | Hannah Brendan CBO, COO & CCO | Option exercise | +2,271 | $0.55 | $1K | 336,547 |
| 2025-12-05 | Hannah Brendan CBO, COO & CCO | Option exercise | +25,280 | $0.94 | $24K | 361,827 |
| 2025-12-05 | Hannah Brendan CBO, COO & CCO | Option exercise · Employee Stock Option (Right to Buy) | −2,271 | 45,168 | ||
| 2025-12-05 | Hannah Brendan CBO, COO & CCO | Option exercise · Employee Stock Option (Right to Buy) | −25,280 | 199,720 | ||
| 2025-06-18 | Hannah Brendan CBO, COO & CCO | Grant or award | +37,736 | $1.20 | $45K | 334,276 |
| 2025-06-18 | Hannah Brendan CBO, COO & CCO | Grant or award · Warrants | +37,736 | $0.13 | $5K | 37,736 |
| 2025-06-18 | Ryan Charles S. President | Grant or award | +7,548 | $1.20 | $9K | 130,009 |
| 2025-06-18 | Ryan Charles S. President | Grant or award · Warrants | +7,548 | $0.13 | $944 | 7,548 |
| 2025-06-18 | Thye Dirk CEO and CMO | Grant or award | +150,944 | $1.20 | $181K | 994,885 |
| 2025-06-18 | Thye Dirk CEO and CMO | Grant or award · Warrants | +150,944 | $0.13 | $19K | 150,944 |
| 2025-06-04 | RYAN UNA S Director | Grant or award · Director Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2025-06-04 | Benatti Luca Director | Grant or award · Director Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2025-06-04 | Senner Christopher J. Director | Grant or award · Director Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2025-06-04 | Lamond David Director | Grant or award · Director Stock Option (Right to Buy) | +27,000 | 27,000 |
Page 2 of 8 · 149 trades